Company / Working Capital per Share
Harmony Biosciences Holdings, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$11.46
FY2025
5-year range
$4.05 / $11.46
FY2021-FY2025
Trend
+61.0%
vs FY2024
Sector context
#41 of 210
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s working capital per share of $11.46 is higher than 80% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 7 years, ranging from $1.49 in FY2019 to $16.48 in FY2020.
Based on SEC 10-K filings.
11.46 in FY2025 with a 5-year CAGR of -7.0%. Top quartile in the Health Care sector.
Improved from $4.82 to $11.46 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +28.0%
- 5-Year CAGR
- -7.0%
- 10-Year CAGR
- -
Sector benchmark
-90.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 61.0% year-over-year.
- Ranks #41 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.46 | +61.0% |
| FY2024 | $7.12 | +47.7% |
| FY2023 | $4.82 | -11.8% |
| FY2022 | $5.46 | +34.8% |
| FY2021 | $4.05 | -75.4% |
| FY2020 | $16.48 | +1004.6% |
| FY2019 | $1.49 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026